Skip to content
Case File
d-27369House OversightOther

Cannabis Industry Segments Report – Production Overview (Dec 2017)

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024668
Pages
1
Persons
3

Summary

The passage is a generic industry overview of cannabis production, containing no references to high‑profile individuals, government agencies, financial misconduct, or controversial actions. It offers Divides cannabis production into cultivation, equipment/supplies, and testing services. Describes cultivation phases and inputs. Published by Ackrell Capital, LLC, a FINRA‑registered firm.

This document is from the House Oversight Committee Releases.

View Source Collection

Persons Referenced (3)

Tags

productionindustry-reportcannabishouse-oversightcultivationequipment
Share
PostReddit

Related Documents (6)

House OversightOtherNov 11, 2025

Ackrell Capital Cannabis OTC Market Valuation Table (2017)

The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.

1p
House OversightOtherNov 11, 2025

Overview of Federal and State Cannabis Regulations and Emerging Policy Shifts

The passage provides a general summary of cannabis regulatory frameworks and mentions recent policy changes (DEA 2016 cultivator expansion, FDA NDA review) but offers no concrete leads, names, transac State governments are adjusting recreational cannabis regulations. Federal law still prohibits cannabis but DOJ and Treasury policies create limited operational space. DEA adopted a 2016 policy to in

1p
House OversightOtherNov 11, 2025

Cannabis Company Valuation Table from Cowen Report (Feb 2019)

The passage is a plain financial data table listing market metrics for cannabis companies. It contains no references to high‑profile individuals, government actions, or alleged misconduct, offering no Provides enterprise values, revenues, and price metrics for dozens of cannabis firms. Cites Thomson Reuters and Cowen as sources. Dated February 25, 2019, with no contextual commentary.

1p
House OversightOtherNov 11, 2025

Directory of Private Cannabis Companies Listed in House Oversight Document

The passage merely lists cannabis businesses and their services without mentioning any high‑profile individuals, government agencies, financial transactions, or allegations of misconduct. It offers no SPARC operates three dispensaries and a delivery service in San Francisco. Steep Hill Labs provides cannabis testing services and proprietary testing technologies. Spectrum King manufactures LED grow

1p
House OversightFinancial RecordNov 11, 2025

Ackrell Capital Cannabis Investment Report (Dec 2017) – Canadian Stock Market Comparison

The document is a routine market analysis with no mention of high‑profile individuals, government agencies, or controversial transactions. It provides generic data on exchange listings and financial c Shows that >10% of Canadian Securities Exchange listings are cannabis‑related. Compares market size and median company values across TSX, TSXV, and CSE. Outlines listing and governance requirements f

1p
House OversightOtherNov 11, 2025

Garble of cannabis industry company names and lab listings

The document is a nonsensical compilation of company and product names in the cannabis sector with no identifiable high‑profile individuals, government agencies, financial transactions, or actionable Contains a list of cannabis cultivators, labs, distributors, and e‑commerce brands. Mentions various trade names (e.g., Peridot Labs, Steep Hill, Trulieve, BudGenius). No dates, transaction details,

1p

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.